ISPOR Conferences and Events
Signal Series
June 21 | 11:00AM – 12:30PM EDT
The Real Experience Revolution®: Towards a New Empiricism of Health
Reserve your complimentary virtual seat and prepare to hear a radical position on the empiricism of health and its interactional creation. Join us as we explore how we can better view real experiences with health, disease, and illness, ask how and why do real experiences form, become different, and recur, and address the origin and persistence of health inequalities and disparities within social groups, places, communities, and populations.
Host:
Daniel Pesut, PhD, RN, Emeritus Professor of Nursing, University of Minnesota, Minneapolis, Minnesota, USA
Guest Speaker:
Christopher Lawer, MPhil, Creator of Umio and the Umio Community, Global Advisor and Educator, and Author of Interactional Creation of Health: Experience Ecosystem Ontology, Task and Method, and Flow: A Short Guide to Real Experience Flow Creation® (May 2022)
The Signal series—ISPOR’s signature program—looks beyond today’s linear thinking to explore topics that will shape healthcare decision making over the next decade. Signal episodes are scheduled throughout the year and feature conversations with speakers who are innovative thought leaders and change makers in both healthcare and other sectors of economy, science disciplines, and areas of human inquiry that can impact healthcare.
Learn more and register at www.ispor.org/signal-ExperienceEcosystems
The conversation begins on Twitter ISPORSignal
ISPOR Europe 2022 | 6-9 November
Austria Center Vienna, Vienna, Austria
Join global healthcare leaders as they convene in Vienna, the “City of Music,” for ISPOR Europe 2022. The 3-day conference will offer in-depth discussion and dissemination of the hottest international topics in health economics and outcomes research (HEOR).
This must-attend event provides you with dedicated opportunities to network in person and virtually with your peers, HEOR experts, and thought leaders to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers. The conference will be complete with plenary sessions, spotlights, a Signal Series episode, breakouts, forums, sponsored educational symposia, poster presentations, and an exhibit hall. Registration fee includes pre- and post-conference access to content on-demand!
The Call for Session Abstracts closes 14 June and the Call for Research Abstracts closes 30 June. Visit our Abstract Information page for ISPOR Europe 2022 to learn more.
Interested in sponsoring or exhibiting at ISPOR Europe 2022? Contact the Sales Team at exhibit@ispor.org.
More at www.ispor.org/Europe2022
Chat with us on Twitter at #ISPOREurope
Virtual ISPOR Asia Pacific Summit 2022 | 20-21 September
The leading HEOR event for Asia Pacific, themed “Linking HEOR Research, Evidence, and Patient Needs for Decision Making in Asia Pacific,” will feature content focusing on in-depth research and discussion of the current state of HEOR in the region, and how HEOR can support health systems confronting practical issues associated to healthcare quality, access, and affordability, and finding potential solutions in the Asia Pacific region. The virtual summit will be held in Korea Standard Time (KST).
The Summit program will feature 2 thought-provoking plenary sessions titled: “Value or Volume: Are APAC Regions Transforming into Value-Based Healthcare?” and “Digital Health Innovations: Improving Patient Outcomes and Equity in the Asia Pacific Region.” In addition, topical issue panels and workshops, and educational symposia will fill the schedule.
Sponsorship opportunities are available. Contact the ISPOR Sales Team at exhibit@ispor.org.
More at www.ispor.org/AsiaPacific2022
Join the conversation on Twitter #ISPORAP
June 7 | 11:00AM EDT
Sustainable Access to Biosimilars in the USA and Latin America: Challenges and Potential Solutions
This webinar leverages recent global research, conducted across 17 countries, to provide an overview of the challenges and solutions to ensuring biosimilar benefits are sustainably delivered to the whole society, with specific focus on issues in the United States and Latin American region.
Sponsored by: Charles River Associates
June 16 | 10:00AM EDT
Oncology Endpoints in Reimbursement Decision-Making: Are We Keeping Pace with the Science?
In this webinar, the speakers will represent differing perspectives on the solutions to achieve patient access in the absence of mature overall survival data. Included will be an outline of how we can use alternative context-relevant endpoints to inform decision-making.
Sponsored by: AstraZeneca
June 23 | 11:00AM EDT
Distributional Cost-Effectiveness Analysis to Inform Healthcare Decisions
This webinar will provide an educational opportunity for ISPOR members to learn about the methods for conducting distributional cost-effectiveness analysis and the resulting equity impacts and trade-offs.
Brought to you by: ISPOR Health Equity Research SIG
Virtual ISPOR Short Courses
June 8-9 | 10:00AM – 12:00PM EDT
Advanced Patient-Reported Outcomes
This course will present steps for successful implementation of PROs in the drug development process that includes: PRO instrument selection, psychometric evaluation, data capture, and interpretation to navigate regulatory, reimbursement, and market access drug development hurdles. Psychometric measurement properties and interpretation of meaningful change for PRO measures will also be reviewed.
June 22-23 | 10:00AM – 12:00PM EDT
Patient Engagement in Medical-Product Research and Development
This half-day course is designed to provide participants with an introduction to patient engagement (PE) in medical-product research through defining PE and providing its historical context and significance throughout ISPOR’s HEOR taxonomy. This course will also equip attendees with tools to plan and implement meaningful PE activities in their respective areas of research expertise (eg, clinical development, epidemiology, health economics, real-world evidence, etc).
June 29-30 | 10:00AM – 12:00PM EDT
Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards
The aim of this course is to explain and demonstrate the steps that are involved in assessing the quality of pharmacoeconomic models, including technical checks regarding the ‘wiring’ of the model, the assessment of the analytical techniques used to generate model inputs and outputs, and the importance of strategic review and assessment.
July 13-14
10:00AM – 12:00PM EDT
Introduction to Use of Electronic Health Record Data for Health Technology Assessment
Electronic health records (EHRs) are increasingly available for health economics and outcomes research yet are unfamiliar to many researchers and analysts. This introductory course will focus on principles for understanding the EHR and how it may be used for research and inform Health Technology Assessments.
July 19-20| 10:00AM – 12:00PM EDT
Multiple Imputation Methods for Addressing Missing Data in Health Economic Evaluation
This course offers an in-depth description of multiple imputation (MI) methods for addressing missing data in cost-effectiveness analyses (CEA). The course provides an overview of the basic principles of MI, as well as more advanced approaches for handling complex features, such as clustering and missing not at random. We illustrate the methods through a series of trial-based CEAs using Stata.
July 26-27 | 10:00AM – 12:00PM EDT
Introduction to Modeling Methods
This course is an introduction to basic modeling methods including decision trees, Markov models and other simulation methods used in pharmacoeconomic evaluation and outcomes research. The course will use the ISPOR-SMDM Joint Modeling Good Research Practices Task Force to explore when and how modeling should be used in economic evaluation and which are the suitable model techniques.
